Abstract
Curcumin (diferuloylmethane, 1, 6-heptadiene-3, 5-5dione-1, 7-bis (4-hydroxy-3-methoxyphenyl)), a constituent of turmeric (curcuma longa), is traditionally used in various diseases. We report the strong anti-oxidative effect of curcumin on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Results show that curcumin protects erythrocyte lipid peroxidation (MDAMalondialdehyde) and decrease of glutathione (GSH) during oxidative stress. The quotient of MDA/GSH is high during stress however presence of curcumin (10-8 M-10-5 M) decreased the index (MDA/GSH) substantiating the antioxidant effect of curcumin in a model cell system. The effect of curcumin is dose-dependent with maximum effect at 10-5M. Since oxidative stress has been implicated in the pathogenesis of many diseases/conditions, a therapeutic role of curcumin is hypothesized.
Keywords: Antioxidant, curcumin, erythrocyte, glutathione, malondialdehyde, oxidative stress, Tert-Butylhydroperoxide, lipid peroxidation, free radical
The Natural Products Journal
Title: Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes
Volume: 2 Issue: 1
Author(s): Prabhakar Singh and Syed Ibrahim Rizvi
Affiliation:
Keywords: Antioxidant, curcumin, erythrocyte, glutathione, malondialdehyde, oxidative stress, Tert-Butylhydroperoxide, lipid peroxidation, free radical
Abstract: Curcumin (diferuloylmethane, 1, 6-heptadiene-3, 5-5dione-1, 7-bis (4-hydroxy-3-methoxyphenyl)), a constituent of turmeric (curcuma longa), is traditionally used in various diseases. We report the strong anti-oxidative effect of curcumin on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative stress by incubating with tert-butylhydroperoxide (t-BHP). Results show that curcumin protects erythrocyte lipid peroxidation (MDAMalondialdehyde) and decrease of glutathione (GSH) during oxidative stress. The quotient of MDA/GSH is high during stress however presence of curcumin (10-8 M-10-5 M) decreased the index (MDA/GSH) substantiating the antioxidant effect of curcumin in a model cell system. The effect of curcumin is dose-dependent with maximum effect at 10-5M. Since oxidative stress has been implicated in the pathogenesis of many diseases/conditions, a therapeutic role of curcumin is hypothesized.
Export Options
About this article
Cite this article as:
Singh Prabhakar and Ibrahim Rizvi Syed, Anti-Oxidative Effect of Curcumin Against Tert-Butylhydroperoxide Induced Oxidative Stress in Human Erythrocytes, The Natural Products Journal 2012; 2 (1) . https://dx.doi.org/10.2174/2210315511202010069
DOI https://dx.doi.org/10.2174/2210315511202010069 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Current Pharmaceutical Design Beyond the Reproductive Effect of Sex Steroids: Their Role During Immunity to Helminth Parasite Infections
Mini-Reviews in Medicinal Chemistry Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
Current Medicinal Chemistry Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine
Current Pharmaceutical Design Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Multiple Roles of Histamine in Autoimmune Demyelinating Disease of the Central Nervous System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
Current Drug Targets - CNS & Neurological Disorders Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer
Current Gene Therapy The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Immunobiology of Antigen-Specific Immunoglobulin Free Light Chains in Chronic Inflammatory Diseases
Current Pharmaceutical Design Mechanism by which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis
Endocrine, Metabolic & Immune Disorders - Drug Targets Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis
Current Pharmaceutical Design Identification of New Susceptibility Genes for Type 1 Diabetes: An Update
Current Immunology Reviews (Discontinued) From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology